The mark consists of the words "INTERVENTIONAL &" above the word "IMMUNO-ONCOLOGY" to the right of a stylized depiction of "IO" with the number "2" in superscript to the right of "IO" in a box.
Mark For: IO2 INTERVENTIONAL & IMMUNO-ONCOLOGY™ trademark registration is intended to cover the categories of
>Color is not claimed as a feature of the mark. The mark consists of the words "INTERVENTIONAL &" above the word "IMMUNO-ONCOLOGY" to the right of a stylized depiction of "IO" with the number "2" in superscript to the right of "IO" in a box.
Research | OneLook Acronym Finder |
Serial Number | 88037659 |
Mark Literal Elements | IO2 INTERVENTIONAL & IMMUNO-ONCOLOGY |
Mark Drawing Type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S) |
Mark Type | TRADEMARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | TMEG LAW OFFICE 103 - EXAMINING ATTORNEY ASSIGNED 2019-12-05 |
Basis | 44(e) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | No |
Filed ITU | Yes |
44D Filed | Yes |
44E Current | Yes |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Jonathan A. Hyman |
Attorney Docket Number | RJENK70.044T |
Law Office Assigned | L30 |
Employee Name | GOLDEN, LAURA DAWN |
2018-07-13 | Application Filed |
2018-11-02 | Trademark Registered |
2018-11-20 | Location: TMEG LAW OFFICE 103 - EXAMINING ATTORNEY ASSIGNED |
2018-11-20 | Status: Live/Pending |
2019-01-03 | Transaction Date |
2019-12-05 | Location: TMEG LAW OFFICE 103 - EXAMINING ATTORNEY ASSIGNED |
2021-06-09 | Status: Suspension check completed. Application remains suspended. |
Party: | BTG International Limited |
Address | 5 Fleet Place London UNITED KINGDOM EC4M7RD |
Legal Entity Type | Private Limited Company |
Legal Entity State | UNITED KINGDOM |
Drawing | JPEG | 2018-07-13 |
TEAS RF New Application | MULTI | 2018-07-13 |
Amended Drawing | JPEG | 2018-07-19 |
Design Search Code Corr Project | APPLICATION/XML | 2018-07-19 |
Drawing | JPEG | 2018-07-19 |
Preliminary Amendment | MULTI | 2018-07-19 |
Amendment and Mail Process Complete | MULTI | 2018-07-21 |
Notation to File | XML | 2018-11-20 |
Offc Action Outgoing | MULTI | 2018-11-20 |
XSearch Search Summary | XML | 2018-11-20 |
XSearch Search Summary | XML | 2018-11-20 |
Response to Office Action | MULTI | 2019-05-10 |
Amendment and Mail Process Complete | MULTI | 2019-05-22 |
Offc Action Outgoing | MULTI | 2019-07-02 |
Response to Office Action | MULTI | 2019-12-03 |
Amendment and Mail Process Complete | MULTI | 2019-12-05 |
Suspension Letter | XML | 2019-12-05 |
Change Address or Representation Form | XML | 2020-08-30 |
26.09.25 | Squares with curved sides |
260921 | Squares that are completely or partially shaded |
260925 | Squares with curved sides |
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; pharmaceutical preparations and substances for use in the circulatory system; pharmaceutical preparations and substances for embolization; pharmaceutical preparations and substances for embolization of tumours and arteriovenous malformations (AVMs); pharmaceutical preparations and substances for use in the circulatory system for the treatment of tumours and AVMs; adjuvants for medicinal purposes, vaccine adjuvants and vaccine preparations containing adjuvant; chemical reagents for medical purposes; transarterial chemoembolization pharmaceutical preparations, vaccines and sera; irradiated or radioactive microspheres used for in vivo therapeutic medical purposes; radiotherapy substances for medical purposes; radiopharmaceuticals; therapeutic agents for delivery of radioactive material to target sites within the body; radioactive substances for medical purposes, namely, microscopic radioactive beads for treatment of cancerous tumours, microscopic glass beads incorporating radioactive material for treatment of cancerous tumours, and radioactive glass beads; pharmaceutical preparations for use in chemotherapy
IC 010. US 026 039 044. G & S: Surgical apparatus and instruments; medical apparatus and instruments for use in the diagnosis and treatment of cancer; Surgical and medical apparatus and instruments, namely, drug delivery systems; apparatus and instruments for embolisation; surgical and medical apparatus and instruments, namely, catheters, injection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; embolisation apparatus, instruments and systems comprising surgical and medical instruments for embolisation; drug delivery embolisation systems; drug delivery apparatus and instruments comprised of injection syringes, and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials; medical apparatus and instruments for embolisation; surgical and medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; radiotherapy apparatus; surgical and medical apparatus and instruments for delivery of radiopharmaceuticals and radioactive material to target sites within the body; implantable radiation therapy devices, namely, microscopic glass beads incorporating radioactive material or containing radioactive material and administered surgically for treatment of cancerous tumours, and radioactive glass beads administered for treatment of cancerous tumours; surgical and medical apparatus and instruments for use in the circulatory system; needles for medical use, namely, cannula needles; medical devices for performing cryotherapy, namely, cryosurgical probes and cryoablation needles used for the minimally invasive cryoablation of cancerous tissues; medical apparatus consisting of treatment probes and high pressure valves used for heat or freeze treatment; surgical, medical and medical diagnostic devices, apparatus and instruments for use in cryoablation, and the treatment of prostate cancer, kidney or renal tumours, and benign prostatic hyperplasia (BPH); medical devices used to deliver heat to target sites using electrical current through needles; medical devices to deliver cryogen gas for freezing and either cryogen gas or electrical current for heating; medical devices for ablating human and animal tissue using microwave energy; medical devices for treating cancerous and benign tissue using microwave energy; replacement and structural parts for all of the aforesaid goods
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 10 |
U.S. Codes: | 026,039,044 |
Type Code | Type |
---|---|
PM0001 | IO TWO INTERVENTIONAL AND IMMUNO-ONCOLOGY |
Description | Date | Proceeding Number |
---|---|---|
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2021-06-09 | |
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2020-12-09 | |
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 2020-08-30 | |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-08-30 | |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-08-30 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-08-30 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-08-30 | |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-08-30 | 88888 |
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2020-06-09 | |
SUSPENSION LETTER WRITTEN | 2019-12-05 | 90286 |
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2019-12-05 | 6332 |
LETTER OF SUSPENSION E-MAILED | 2019-12-05 | 6332 |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-12-04 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-12-03 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-12-03 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-07-02 | 6325 |
NON-FINAL ACTION WRITTEN | 2019-07-02 | 90286 |
NON-FINAL ACTION E-MAILED | 2019-07-02 | 6325 |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-05-21 | 70468 |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-05-21 | 70468 |
ASSIGNED TO LIE | 2019-05-19 | 70468 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-05-10 | |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-11-20 | 6325 |
NON-FINAL ACTION WRITTEN | 2018-11-20 | 90286 |
NON-FINAL ACTION E-MAILED | 2018-11-20 | 6325 |
ASSIGNED TO EXAMINER | 2018-10-31 | 90286 |
TEAS VOLUNTARY AMENDMENT RECEIVED | 2018-07-19 | |
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | 2018-07-19 | 88889 |
NOTICE OF DESIGN SEARCH CODE E-MAILED | 2018-07-19 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-07-18 | |
NEW APPLICATION ENTERED IN TRAM | 2018-07-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.